Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 23, 2022 06:00 ET | Source: CDR-Life AG

CDR-Life Announces Appointment of Swethajit Biswas, MD, as Chief Medical Officer

ZÜRICH, Switzerland, Aug. 23, 2022 (GLOBE NEWSWIRE) -- CDR-Life Inc., a biotechnology company pioneering a new and differentiated class of highly tumor-selective immuno-oncology therapeutics...
April 13, 2022 06:00 ET | Source: CDR-Life AG

CDR-Life Announces $76 Million Raised in Series A Funding

ZÜRICH, Switzerland, April 13, 2022 (GLOBE NEWSWIRE) -- CDR-Life Inc., a biotechnology company pioneering a new and differentiated class of highly tumor-specific immuno-oncology therapeutics...
March 22, 2022 10:56 ET | Source: CDR-Life AG

CORRECTION -- CDR-Life to Present at the American Association for Cancer Research 2022 Annual Meeting

ZÜRICH, Switzerland, March 22, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by CDR-Life, please note that in the second paragraph of the release, the...
March 22, 2022 07:00 ET | Source: CDR-Life AG

CDR-Life to Present at the American Association for Cancer Research 2022 Annual Meeting

ZÜRICH, Switzerland, March 22, 2022 (GLOBE NEWSWIRE) -- CDR-Life Inc., a biotechnology company pioneering a new and differentiated class of highly tumor-specific immuno-oncology therapeutics...
December 13, 2021 06:00 ET | Source: CDR-Life AG

CDR-Life Announces Positive Preclinical Data on CDR101 Program Presented at the American Society of Hematology’s 2021 Annual Meeting

ZÜRICH, Switzerland, Dec. 13, 2021 (GLOBE NEWSWIRE) -- CDR-Life Inc., a biotechnology company pioneering a new and differentiated class of highly tumor-specific immuno-oncology therapeutics...
November 08, 2021 09:00 ET | Source: CDR-Life AG

CDR-Life to Present at the American Society of Hematology’s 2021 Annual Meeting

ZÜRICH, Switzerland, Nov. 08, 2021 (GLOBE NEWSWIRE) -- CDR-Life Inc., a biotechnology company pioneering a new and differentiated class of highly tumor-specific immuno-oncology therapeutics...
October 26, 2021 03:00 ET | Source: CDR-Life AG

CDR-Life Announces Expansion of Scientific Advisory Board

ZÜRICH, Switzerland, Oct. 26, 2021 (GLOBE NEWSWIRE) -- CDR-Life Inc., a biotechnology company pioneering a new and differentiated class of highly tumor-specific immuno-oncology therapeutics...
September 08, 2021 03:00 ET | Source: CDR-Life AG

CDR-Life Announces the Advancement of Antibody Treatment for Patients with Geographic Atrophy with Development Partner Boehringer Ingelheim

ZÜRICH, Switzerland, Sept. 08, 2021 (GLOBE NEWSWIRE) -- CDR-Life Inc., today announced that Boehringer Ingelheim has selected an antibody fragment-based therapeutic candidate for advancement to...